Table 2 Survival Patterns of Advanced Renal Cell Carcinoma Patients Across Both Age Groups in the ICI and Non-ICI Eras.

From: Age-Related Survival Disparities in Advanced Renal Carcinoma in the Immune Checkpoint Inhibitor Era using the SEER Database and Meta-analysis

Parameters

<65 years group

\(\ge\)65 years group

(median months)

(median months)

Non-ICI era

ICI era

Log rank

Non-ICI era

ICI era

Log rank

(7 months)

(16 months)

P value

(6 months)

(13 months)

P value

Sex

Male

7

17

0.0001

6

14

0.0001

Female

7

15

0.0001

6

11

0.0001

Race

White

7

17

0.0001

6

13

0.0001

Black

6

11

0.0001

6

9

0.0001

Others

8

18

0.0001

6

16

0.0001

Marital status

Yes

7

18

0.0001

6

14

0.0001

Others

7

14

0.0001

6

11

0.0001

Laterality

Both side

5

6

0.49

4

4

0.135

Right side

7

17

0.0001

6

13

0.0001

Left side

7

16

0.0001

6

14

0.0001

Surgery status

Performed

9

22

0.0001

10

21

0.0001

Others

5

7

0.0001

4

6

0.0001

Radiation status

Yes

6

10

0.0001

5

7

0.0001

No

7

19

0.0001

6

16

0.0001

Chemotherapy

Yes

8

11

0.0001

7

10

0.0001

No

6

20

0.0001

5

16

0.0001

Metastatic site

Bone

Yes

6

8

0.0001

4

6

0.0001

No

8

20

0.0001

7

17

0.0001

Brain

Yes

5

6

0.0001

4

4

0.0001

No

8

18

0.0001

7

14

0.0001

Liver

Yes

5

5

0.0001

4

4

0.0001

No

8

18

0.0001

7

15

0.0001

Lung

Yes

6

9

0.0001

5

6

0.0001

No

9

21

0.0001

8

19

0.0001

Grade

Well, moderate

10

17

0.0001

9

23

0.0001

Poor, undifferentiated

8

20

0.0001

8

19

0.0001

Income

< $60,000

7

15

0.0001

6

11

0.0001

> $60,000

7

17

0.0001

6

13

0.0001

Tumor size

< 4 cm

7

21

0.0001

6

17

0.0001

4-7 cm

8

20

0.0001

6

18

0.0001

>7 cm

7

14

0.0001

6

11

0.0001